ES2160190T3 - Esteres de acido sulfurico de alcoholes de azucar para la inhibicion de la migracion y proliferacion de celulas de los musculos lisos de las paredes vasculares. - Google Patents

Esteres de acido sulfurico de alcoholes de azucar para la inhibicion de la migracion y proliferacion de celulas de los musculos lisos de las paredes vasculares.

Info

Publication number
ES2160190T3
ES2160190T3 ES96106471T ES96106471T ES2160190T3 ES 2160190 T3 ES2160190 T3 ES 2160190T3 ES 96106471 T ES96106471 T ES 96106471T ES 96106471 T ES96106471 T ES 96106471T ES 2160190 T3 ES2160190 T3 ES 2160190T3
Authority
ES
Spain
Prior art keywords
sup
radical
derivative
independently
decreased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96106471T
Other languages
English (en)
Inventor
Alexander Chucholowski
Michael Pech
Jurgen Fingerle
Marianne Rouge
Niggi Iberg
Gerard Schmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2160190T3 publication Critical patent/ES2160190T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06—Hydrogenosulfates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE NUEVOS ESTERES DE ACIDO SULFURICO Y DE COMPUESTOS SIMILARES A LOS ALCOHOLES DE AZUCAR DE FORMULA GENERAL IA Y IB EN DONDE N{SUP,1} - N{SUP,9} SON 0 O 1, INDEPENDIENTEMENTE UNO DE OTRO; Y M{SUP,1} - M{SUP,9} SON 0 O 1 INDEPENDIENTEMENTE UNO DE OTRO, CON LA CONDICION DE QUE AL MENOS UNO DE M{SUP,1}, M{SUP,2} O M{SUP,3}, AL MENOS UNO DE M{SUP,4}, M{SUP,5} O M{SUP,6}, Y SI EXISTE, AL MENOS UNO DE M{SUP,7}, M{SUP,8} O M{SUP,9} SEAN 1; Y EN DONDE X{SUP,1}- V{SUP,18} SON INDEPENDIENTEMENTE UNO DE OTRO -O-, CONR{SUP,1}-, -NR{SUP,1}CO-, -NR{SUP,1}-; R{SUP,1} ES HIDROGENO O ALQUILO DE CADENA CORTA; W ES UN RADICAL DE BENCENO O UN RADICAL DE S-TRIAZINA; Y{SUP,1} - Y{SUP,9} SON SISTEMAS CICLICOS AROMATICOS INDEPENDIENTEMENTE UNO DE OTRO; A{SUP,1} - A{SUP,3} SON, INDEPENDIENTEMENTE UNO DE OTRO, UN RADICAL DISMINUIDO EN 1 GRUPO HIDROXILO DE UN ALCOHOL DE AZUCAR, O UN DERIVADO, UN RADICAL DISMINUIDO EN 1 GRUPO CARBOXILO DE UN ACIDO CARBOXILICO DE AZUCAR, O UN DERIVADO, UN RADICAL TRIS(HIDROXIMETIL)-METILO; D ES UN RADICAL DOBLE DE UN ALCOHOL DE AZUCAR DISMINUIDO EN DOS GRUPOS HIDROXILOS, O UN DERIVADO, O UN RADICAL DOBLE DE UN ACIDO DICARBOXILICO DE AZUCAR DISMINUIDO EN DOS GRUPOS CARBOXILOS, O UN DERIVADO; Q{SUP,1} - Q{SUP,3} Y Z{SUP,1} - Z{SUP,3} SON, INDEPENDIENTEMENTE UNO DE OTRO, UN RADICAL DOBLE DE UN ALCOHOL DE AZUCAR DISMINUIDO EN 2 GRUPOS HIDROXILOS, O UN DERIVADO, O UN RADICAL DOBLE DE UN ACIDO DICARBOXILICO DE AZUCAR DISMINUIDO EN 2 GRUPOS CARBOXILOS, O UN DERIVADO, O UN RADICAL DOBLE DE DESOXIGLUCOPIRANOSA, O UN DERIVADO, ESTANDO ESTERIFICADO CON ACIDO SULFURICO AL MENOS UN GRUPO HIDROXILO DE LOS RADICALES A{SUP,1} - A{SUP,3}, D, Q{SUP,1} - Q{SUP,3} Y Z{SUP,1} - Z{SUP,3}; Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. LOS COMPUESTOS DE ACUERDO CON LA INVENCION, COMO POR EJEMPLO ESTAN INDICADOS EN EL TRATAMIENTO DE ENFERMEDADES, QUE SE CARACTERIZAN POR UNA PROLIFERACION EXCESIVA O DESTRUCTIVA DE CELULAS DE MUSCULO LISO.
ES96106471T 1995-05-05 1996-04-24 Esteres de acido sulfurico de alcoholes de azucar para la inhibicion de la migracion y proliferacion de celulas de los musculos lisos de las paredes vasculares. Expired - Lifetime ES2160190T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH131095 1995-05-05

Publications (1)

Publication Number Publication Date
ES2160190T3 true ES2160190T3 (es) 2001-11-01

Family

ID=4207454

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96106471T Expired - Lifetime ES2160190T3 (es) 1995-05-05 1996-04-24 Esteres de acido sulfurico de alcoholes de azucar para la inhibicion de la migracion y proliferacion de celulas de los musculos lisos de las paredes vasculares.

Country Status (15)

Country Link
US (1) US5830920A (es)
EP (1) EP0741128B1 (es)
JP (1) JP2881752B2 (es)
CN (1) CN1150589A (es)
AR (1) AR003945A1 (es)
AT (1) ATE202339T1 (es)
BR (1) BR9602148A (es)
CA (1) CA2174583A1 (es)
DE (1) DE59607115D1 (es)
DK (1) DK0741128T3 (es)
ES (1) ES2160190T3 (es)
GR (1) GR3036660T3 (es)
MX (1) MX9601521A (es)
PT (1) PT741128E (es)
TR (1) TR199600329A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6864219B2 (en) 2000-01-17 2005-03-08 Bayer Aktiengesellschaft Substituted aryl ketones
DE60111948T2 (de) 2000-09-07 2006-04-20 TELIK, INC., Palo Alto Benzoltricarbonsäureamide als aktivatoren des insulinrezeptors
US7354747B1 (en) * 2003-05-08 2008-04-08 The Regents Of The University Of California Carbohydrate derived protein resistant biomaterial
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
CA2751125C (en) * 2009-01-29 2017-06-20 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
CN104869993B (zh) 2012-10-25 2019-01-15 通用医疗公司 治疗阿尔茨海默病及相关疾病的组合疗法
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
US10188757B2 (en) 2013-10-22 2019-01-29 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
WO2015151068A1 (en) * 2014-04-03 2015-10-08 Universita' Di Pisa Synthetic analogues of 3-iodothyronamine (t1am) and uses thereof
WO2015150995A1 (en) 2014-04-04 2015-10-08 Pfizer Inc. Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
EP3506894B1 (en) 2016-08-31 2023-08-23 The General Hospital Corporation Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
WO2019017995A1 (en) 2017-07-20 2019-01-24 Aztherapies, Inc. FORMULATIONS OF CROMOLYNE SODIUM POWDER AND IBUPROFEN
AU2019299347A1 (en) 2018-07-02 2021-01-21 Aztherapies, Inc. Powdered formulations of cromolyn sodium and alpha-lactose
US20220218652A1 (en) * 2018-09-05 2022-07-14 The General Hospital Corporation Methods of treating cytokine release syndrome

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8612940D0 (en) * 1986-05-28 1986-07-02 Dow Chemical Co Derivative esters
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
DE3734853A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Bis-aldonsaeureamide und verfahren zu ihrer herstellung
US5298616A (en) * 1990-10-03 1994-03-29 Hoffmann-La Roche Inc. Sulfated O-polysaccharide-trehaloses
CA2061370A1 (en) * 1991-03-13 1992-09-14 Markus Hosang Pharmaceutical preparations
TW308598B (es) * 1994-01-14 1997-06-21 Hoffmann La Roche

Also Published As

Publication number Publication date
TR199600329A2 (tr) 1997-03-21
CA2174583A1 (en) 1996-11-06
ATE202339T1 (de) 2001-07-15
BR9602148A (pt) 2005-06-21
PT741128E (pt) 2001-11-30
CN1150589A (zh) 1997-05-28
US5830920A (en) 1998-11-03
EP0741128A3 (de) 1997-03-26
MX9601521A (es) 1997-02-28
EP0741128A2 (de) 1996-11-06
DE59607115D1 (de) 2001-07-26
JP2881752B2 (ja) 1999-04-12
AR003945A1 (es) 1998-09-30
JPH08301839A (ja) 1996-11-19
GR3036660T3 (en) 2001-12-31
EP0741128B1 (de) 2001-06-20
DK0741128T3 (da) 2001-10-15

Similar Documents

Publication Publication Date Title
ES2160190T3 (es) Esteres de acido sulfurico de alcoholes de azucar para la inhibicion de la migracion y proliferacion de celulas de los musculos lisos de las paredes vasculares.
ES2113664T3 (es) Derivados de aminoacidos como inhibidores de la no sintasa.
ES2152444T3 (es) Derivados de acido benzazepin-, benzoxazepin- y benzotiazepin-n-acetico, asi como procedimiento para su preparacion y medicamentos que contienen a estos compuestos.
ES2101420T3 (es) Esteres-amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
MX9400206A (es) Derivados de vinil-azaindol, proceso para su preparacion y composiciones farmaceuticas que los contienen.
PA8481201A1 (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-amino
ES2164184T3 (es) Esteres de poliaspartato hiperramificados y procedimiento para su preparacion.
DK1624014T3 (da) Specifikke acylerede glycerolforbindelser som blödgöringsmidler i polymerer og fremgangsmåde til deres fremstilling
ES2067466T3 (es) Dispersante.
ES2124062T3 (es) Derivados de nucleosido fosforotioato, sintesis y uso de los mismos.
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
DK1000008T3 (da) Hidtil ukendte thyroideareceptorligander og fremgangsmåde
DK94188D0 (da) Maettede fedtsyreamider som inhibitorer for kolesterol-acyltransferase
DE69426629D1 (de) Therapeutische verbindung - fettsäurekonjugate
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
HUP0003274A2 (hu) Fenil-metil-benzokinon-származékok, és ezeket a vegyületeket tartalmazó NF-kB inhibitor hatású gyógyszerkészítmények
ES2137694T3 (es) Sales de metales pesados de los semiesteres del acido succinico con el acido hialuronico, o con los esteres del acido hialuronico. un proceso para la preparacion y composiciones farmaceuticas relacionadas.
ES2147629T3 (es) Guanidinas de acido alquenilcarboxilico sustituidas con un grupo fluorofenilo como inhibidores del intercambio de na+/nh+, su procedimiento de preparacion y su uso como medicamento o agente diagnostico asi como el medicamento que las contiene.
BR9808430A (pt) Método para melhorar a especificidade da regulação de gens em um organismo transformado
Khanum et al. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes
ES2188923T3 (es) Procedimiento de preparacion de resinas de polieterester a partir de diesteres diolicos.
ES2170956T3 (es) Derivados 2-alquenilicos de acido ciclopentan(en)oico como agentes terapeuticos en el tratamiento de hipertension ocular.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2009856B3 (es) Un procedimiento para producir fosforilalcanolamidas de l-carnitina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 741128

Country of ref document: ES